Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Johnson

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
The Journal of Molecular Diagnostics : JMD|July 24, 2025
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic RecommendationsDanielle K Manning, Guruprasad Ananda, Cheryl Eifert, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 2022
Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancerValerie W Rusch, Alan Nicholas, G Alexander Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2024
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung CancerBiagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, et al.
Nature|August 7, 2007
LKB1 modulates lung cancer differentiation and metastasisHongbin Ji, Matthew R Ramsey, D Neil Hayes, et al.
Nature Medicine|June 24, 2020
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Itay Tirosh, Elizabeth H Stover, et al.
Clinical Lung Cancer|February 28, 2025
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) PatientsAdriana P C Barrichello, Arielle Elkrief, Biagio Ricciuti, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Cell|April 18, 2020
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell ResolutionOrit Rozenblatt-Rosen, Aviv Regev, Philipp Oberdoerffer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 29, 2023
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLCJoao V Alessi, Xinan Wang, Arielle Elkrief, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
The Journal of Molecular Diagnostics : JMD|July 24, 2025
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic RecommendationsDanielle K Manning, Guruprasad Ananda, Cheryl Eifert, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 2022
Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancerValerie W Rusch, Alan Nicholas, G Alexander Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2024
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung CancerBiagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, et al.
Nature|August 7, 2007
LKB1 modulates lung cancer differentiation and metastasisHongbin Ji, Matthew R Ramsey, D Neil Hayes, et al.
Nature Medicine|June 24, 2020
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Itay Tirosh, Elizabeth H Stover, et al.
Clinical Lung Cancer|February 28, 2025
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) PatientsAdriana P C Barrichello, Arielle Elkrief, Biagio Ricciuti, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Cell|April 18, 2020
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell ResolutionOrit Rozenblatt-Rosen, Aviv Regev, Philipp Oberdoerffer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 29, 2023
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLCJoao V Alessi, Xinan Wang, Arielle Elkrief, et al.
Pageof 25